Peripheral artery disease has been estimated to affect more than 10 million people in the US and is a multilevel disease involving the femoropopliteal system in more than 50% of cases. Balloon angioplasty remains the most frequently used technology in the treatment of SFA disease either as primary or adjunctive therapy for stents and other devices.
However, severely calcified coronary lesions respond poorly to balloon angioplasty, resulting in incomplete and asymmetrical stent expansion. Therefore, adequate plaque modification prior to drug-eluting stent (DES) implantation is the key for calcified lesion treatment. Cutting balloons and scoring balloons are commonly used for the preparation of calcified lesion for its better crossability.
TrandoMed can provide various vascular model for R&D, testing and demonstration of your scoring and cutting balloons. More information, contact us at email@example.com.